Phase IV Trial of Miltefosine in Adults and Children for Treatment of Visceral Leishmaniasis (Kala-Azar) in Bangladesh

Miltefosine (target dose of 2.5 mg/kg/day for 28 days) is the recommended treatment for visceral leishmaniasis (kala-azar) in Bangladesh on the basis of data from India. We evaluated miltefosine in a phase IV trial of 977 patients in Bangladesh. At the six-month final follow up, 701 were cured. 24 s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rahman, Mahmudur, Ahmed, Be-Nazir, Faiz, M. Abul, Chowdhury, M. Zafor Ullah, Islam, Quazi Tarikul, Sayeedur, Rahman, Rahman, M. Ridwanur, Hossain, Moazzem, Bangali, Abdul Mannan, Ahmad, Ziauddin, Islam, M. Nazrul, Mascie-Taylor, C. G. Nicholas, Berman, Jonathan, Arana, Byron
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122346/
https://ncbi.nlm.nih.gov/pubmed/21734127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados